Publication | Open Access

Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr−/− murine model of autoimmune lymphoproliferative syndrome (ALPS)

Valproic AcidAutoimmune DiseaseAutoantibody ProductionLupusImmunodeficienciesMedicineImmunologyPathologyAutoimmunityAutoantigensAutoantibodiesImmunologic DiseasePharmacologyHistone DeacetylaseCell SignalingAutoimmune Lymphoproliferative Syndrome